This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Imperial Innovations Limited. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: Albert Andrzej Jaxa-Chamiec: Innovator in Cancer Treatment
Introduction
Albert Andrzej Jaxa-Chamiec is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment and inflammatory diseases. With a total of 2 patents, his work is recognized for its potential impact on medical science.
Latest Patents
Jaxa-Chamiec's latest patents focus on Gadd45beta targeting agents. These patents include compounds based around tetrapeptide, tripeptide, and dipeptide moieties, along with corresponding peptoid moieties. The related methods and pharmaceutical compositions are designed for use in the treatment of cancer, inflammatory diseases, and other disorders.
Career Highlights
He is currently associated with Imperial Innovations Limited, where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
Throughout his career, Jaxa-Chamiec has collaborated with esteemed colleagues such as Guido Franzoso and Caroline Minli Rachel Low. These partnerships have further enhanced the scope and impact of his research.
Conclusion
Albert Andrzej Jaxa-Chamiec stands out as a dedicated inventor whose work in pharmaceuticals is paving the way for new treatments in cancer and inflammatory diseases. His contributions are vital to the ongoing advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile